MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0113426
Wellgrow Pharma Private Limited
Wellgrow Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.66 Cr
▼ 24% YoY
Net profit · FY 2025
₹3.34 Lakh
Net margin 0.6%
EBITDA · FY 2025
₹4.9 Lakh
EBITDA margin 0.9%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Wellgrow Pharma Private Limited
Data last updated:
Wellgrow Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2019PTC319513. Its GSTIN is 27AACCW3518N1ZY (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Minal Vinod Shinkar and Shubhra Nitin Lakhan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No. 303 3rd Fllor Hill View Ind. Estate Off Lbs Marg Ghatkopar (W), Mumbai, Maharashtra, India – 400086.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.66 Cr, a decline of 24% compared to the previous year. For the same year it recorded a net profit of ₹3.34 Lakh (net margin 0.6%) and EBITDA of ₹4.9 Lakh (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years.
Wellgrow Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0113426). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24239MH2019PTC319513
Registration Number 319513
Incorporation Date 14 January 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0113426
Recognitions & Rankings of Wellgrow Pharma
Contact details
Wellgrow Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressUnit No. 303 3rd Fllor Hill View Ind. Estate Off Lbs Marg Ghatkopar (W), Mumbai, Maharashtra, India – 400086
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Wellgrow Pharma Private Limited, buy the company report.
Comprehensive company report
Wellgrow Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Wellgrow Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Wellgrow Pharma Private Limited, buy the company report.
Financials of Wellgrow Pharma Private Limited
FY 2025 filings availableWellgrow Pharma Private Limited reported revenue of ₹5.66 Cr (down 24% YoY) for FY 2025.
Revenue · FY 2025
₹5.66 Cr ▼ 24%
Net profit · FY 2025
₹3.34 Lakh margin 0.6%
EBITDA · FY 2025
₹4.9 Lakh margin 0.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 24%
3 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▼ 65%
3 years · compounded
▲ 4%
Revenue fell 24% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA fell 65% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.9 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.34 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wellgrow Pharma Private Limited, buy the company report.
Board of directors of Wellgrow Pharma Private Limited
Wellgrow Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Minal Vinod Shinkar Also directs: MVS Welljanhit Medicare Private Limited, SS Pharma Vision Private Limited, SS Lifevision Private Limited and 1 more | Director | 14 Jan 2019 | 7 Years 9 Months | Current |
| Shubhra Nitin Lakhan | Director | 14 Jan 2019 | 7 Years 9 Months | Current |
Auditor
Wellgrow Pharma Private Limited is audited by M O B & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M O B & ASSOCIATES | FY 2023 | 136412W |
Legal cases
No court or tribunal cases involving Wellgrow Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wellgrow Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Wellgrow Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCW3518N1ZY | Maharashtra | Active | 01 Apr 2019 |
To see the full GST registrations and return filing status of Wellgrow Pharma Private Limited, buy the company report.
Recent activity
Wellgrow Pharma Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Vinay Vitthal Hadawle ceased to be Director on 16 Nov 2020.
AGM
Wellgrow Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Wellgrow Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Vinay Vitthal Hadawle ceased to be Director.
Appointed
Minal Vinod Shinkar was appointed as Director.
Appointed
Shubhra Nitin Lakhan was appointed as Director.
Appointed
Vinay Vitthal Hadawle was appointed as Director.
Incorporation
14 Jan 2019
Wellgrow Pharma Private Limited was registered on 14 Jan 2019 with Roc Mumbai & aged 7 years 9 months as per MCA records.
Frequently asked questions
Wellgrow Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 January 2019 (7+ years old) and is registered under CIN U24239MH2019PTC319513.
Wellgrow Pharma has 2 current directors:
- Minal Vinod Shinkar - Director
- Shubhra Nitin Lakhan - Director
The latest financial statements of Wellgrow Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Wellgrow Pharma is 27AACCW3518N1ZY, registered in Maharashtra.
The CIN (Corporate Identification Number) of Wellgrow Pharma is U24239MH2019PTC319513. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wellgrow Pharma was incorporated on 14 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Vinay Vitthal Hadawle ceased to be Director on 16 Nov 2020. Minal Vinod Shinkar was appointed as Director on 14 Jan 2019. Shubhra Nitin Lakhan was appointed as Director on 14 Jan 2019. Wellgrow Pharma has 4 board changes on record in total.
Yes, Wellgrow Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0113426).
The registered office of Wellgrow Pharma is at Unit No. 303 3rd Fllor Hill View Ind. Estate Off Lbs Marg Ghatkopar W, Mumbai, Maharashtra, India – 400086.
Wellgrow Pharma operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages